{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:43:59Z","timestamp":1782301439454,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6990","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1038\/nature02626","type":"journal-article","created":{"date-parts":[[2004,5,26]],"date-time":"2004-05-26T21:02:53Z","timestamp":1085605373000},"page":"464-468","source":"Crossref","is-referenced-by-count":601,"title":["Moving towards individualized medicine with pharmacogenomics"],"prefix":"10.1038","volume":"429","author":[{"given":"William E.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary V.","family":"Relling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnature02626_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1126\/science.286.5439.487","volume":"286","author":"WE Evans","year":"1999","unstructured":"Evans, W. E. & Relling, M. V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286, 487\u2013491 (1999).","journal-title":"Science"},{"key":"BFnature02626_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0163-7258(89)90130-7","volume":"41","author":"ES Vesell","year":"1989","unstructured":"Vesell, E. S. Pharmacogenetic perspectives gained from twin and family studies. Pharmacol. Ther. 41, 535\u2013552 (1989).","journal-title":"Pharmacol. Ther."},{"key":"BFnature02626_CR3","first-page":"1175","volume":"26","author":"FP Guengerich","year":"1998","unstructured":"Guengerich, F. P. et al. Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs. Drug Metab. Dispos. 26, 1175\u20131178 (1998).","journal-title":"Drug Metab. Dispos."},{"key":"BFnature02626_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.pharmtox.37.1.269","volume":"37","author":"UA Meyer","year":"1997","unstructured":"Meyer, U. A. & Zanger, U. M. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu. Rev. Pharmacol. Toxicol. 37, 269\u2013296 (1997).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFnature02626_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/331442a0","volume":"331","author":"FJ Gonzalez","year":"1988","unstructured":"Gonzalez, F. J. et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 331, 442\u2013446 (1988).","journal-title":"Nature"},{"key":"BFnature02626_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1146\/annurev.genom.2.1.9","volume":"2","author":"WE Evans","year":"2001","unstructured":"Evans, W. E. & Johnson, J. A. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu. Rev. Genomics Hum. Genet. 2, 9\u201339 (2001).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"BFnature02626_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra020021","volume":"348","author":"R Weinshilboum","year":"2003","unstructured":"Weinshilboum, R. Inheritance and drug response. N. Engl. J. Med. 348, 529\u2013537 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnature02626_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra020526","volume":"348","author":"WE Evans","year":"2003","unstructured":"Evans, W. E. & McLeod, H. L. Pharmacogenomics \u2014 drug disposition, drug targets, and side effects. N. Engl. J. Med. 348, 538\u2013549 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnature02626_CR9","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1200\/JCO.2001.19.8.2293","volume":"19","author":"WE Evans","year":"2001","unstructured":"Evans, W. E. et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J. Clin. Oncol. 19, 2293\u20132301 (2001).","journal-title":"J. Clin. Oncol."},{"key":"BFnature02626_CR10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0022-3476(05)83063-X","volume":"119","author":"WE Evans","year":"1991","unstructured":"Evans, W. E., Horner, M., Chu, Y. Q., Kalwinsky, D. & Roberts, W. M. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. J. Pediatr. 119, 985\u2013989 (1991).","journal-title":"J. Pediatr."},{"key":"BFnature02626_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1126\/science.302.5645.588","volume":"302","author":"E Marshall","year":"2003","unstructured":"Marshall, E. Preventing toxicity with a gene test. Science 302, 588\u2013590 (2003).","journal-title":"Science"},{"key":"BFnature02626_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/425760a","volume":"425","author":"A Abbott","year":"2003","unstructured":"Abbott, A. With your genes? Take one of these, three times a day. Nature 425, 760\u2013762 (2003).","journal-title":"Nature"},{"key":"BFnature02626_CR13","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1001\/jama.286.18.2270","volume":"286","author":"KA Phillips","year":"2001","unstructured":"Phillips, K. A., Veenstra, D. L., Oren, E., Lee, J. K. & Sadee, W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. J. Am. Med. Assoc. 286, 2270\u20132279 (2001).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnature02626_CR14","first-page":"R94","volume":"287","author":"M Eichelbaum","year":"1975","unstructured":"Eichelbaum, M., Spannbrucker, N. & Dengler, H. J. N-oxidation of sparteine in man and its interindividual differences. Naunyn Schmiedebergs Arch. Pharmacol. 287, R94 (1975).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"BFnature02626_CR15","doi-asserted-by":"crossref","unstructured":"Mahgoub, A., Idle, J. R., Dring, L. G., Lancaster, R. & Smith, R. L. Polymorphic hydroxylation of Debrisoquine in man. Lancet 2, 584\u2013586 (1977).","DOI":"10.1016\/S0140-6736(77)91430-1"},{"key":"BFnature02626_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0165-6147(99)01363-2","volume":"20","author":"M Ingelman-Sundberg","year":"1999","unstructured":"Ingelman-Sundberg, M., Oscarson, M. & McLellan, R. A. Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends Pharmacol. Sci. 20, 342\u2013349 (1999).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnature02626_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ng1151","volume":"34","author":"MH Cheok","year":"2003","unstructured":"Cheok, M. H. et al. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nature Genet. 34, 85\u201390 (2003).","journal-title":"Nature Genet."},{"key":"BFnature02626_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1073\/pnas.98.2.581","volume":"98","author":"KH Buetow","year":"2001","unstructured":"Buetow, K. H. et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry. Proc. Natl Acad. Sci. USA 98, 581\u2013584 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature02626_CR19","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.286.18.2211","volume":"286","author":"LA Liotta","year":"2001","unstructured":"Liotta, L. A., Kohn, E. C. & Petricoin, E. F. Clinical proteomics: personalized molecular medicine. J. Am. Med. Assoc. 286, 2211\u20132214 (2001).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnature02626_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nm0503-510","volume":"9","author":"TR Golub","year":"2003","unstructured":"Golub, T. R. Mining the genome for combination therapies. Nature Med. 9, 510\u2013511 (2003).","journal-title":"Nature Med."},{"key":"BFnature02626_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/ng1305","volume":"36","author":"K Stegmaier","year":"2004","unstructured":"Stegmaier, K. et al. Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation. Nature Genet. 36, 257\u2013263 (2004).","journal-title":"Nature Genet."},{"key":"BFnature02626_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ng0304-214","volume":"36","author":"WE Evans","year":"2004","unstructured":"Evans, W. E. & Guy, R. K. Gene expression as a drug discovery tool. Nature Genet. 36, 214\u2013215 (2004).","journal-title":"Nature Genet."},{"key":"BFnature02626_CR23","doi-asserted-by":"crossref","unstructured":"Mallal, S. et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359, 727\u2013732 (2002).","DOI":"10.1016\/S0140-6736(02)07873-X"},{"key":"BFnature02626_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/86882","volume":"27","author":"P Kuehl","year":"2001","unstructured":"Kuehl, P. et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nature Genet. 27, 383\u2013391 (2001).","journal-title":"Nature Genet."},{"key":"BFnature02626_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1126\/science.302.5645.594","volume":"302","author":"C Holden","year":"2003","unstructured":"Holden, C. Race and medicine. Science 302, 594\u2013596 (2003).","journal-title":"Science"},{"key":"BFnature02626_CR26","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1126\/science.1078311","volume":"298","author":"NA Rosenberg","year":"2002","unstructured":"Rosenberg, N. A. et al. Genetic structure of human populations. Science 298, 2381\u20132385 (2002).","journal-title":"Science"},{"key":"BFnature02626_CR27","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1056\/NEJMsb025007","volume":"348","author":"EG Burchard","year":"2003","unstructured":"Burchard, E. G. et al. The importance of race and ethnic background in biomedical research and clinical practice. N. Engl. J Med. 348, 1170\u20131175 (2003).","journal-title":"N. Engl. J Med."},{"key":"BFnature02626_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0140-6736(03)12213-1","volume":"361","author":"DM Eccles","year":"2003","unstructured":"Eccles, D. M. Genetic testing for BRCA1 mutation in the UK. Lancet 361, 178\u2013179 (2003).","journal-title":"Lancet"},{"key":"BFnature02626_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00008571-200301000-00002","volume":"13","author":"RB Altman","year":"2003","unstructured":"Altman, R. B. et al. Indexing pharmacogenetic knowledge on the World Wide Web. Pharmacogenetics 13, 3\u20135 (2003).","journal-title":"Pharmacogenetics"},{"key":"BFnature02626_CR30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nrg1229","volume":"4","author":"DB Goldstein","year":"2003","unstructured":"Goldstein, D. B., Tate, S. K. & Sisodiya, S. M. Pharmacogenetics goes genomic. Nature Rev. Genet. 4, 937\u2013947 (2003).","journal-title":"Nature Rev. Genet."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature02626.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature02626","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature02626.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:24:09Z","timestamp":1684434249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature02626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":30,"journal-issue":{"issue":"6990","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["BFnature02626"],"URL":"https:\/\/doi.org\/10.1038\/nature02626","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}